Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership
All
13F
13D/G
Other
Tags
CC transcript
|
|
ASTRAZENECA PLC (AZN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/18/2021 |
GN
| AZN INVESTOR NOTICE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important March 29 Deadline in Securities Class Action – AZN |
| 03/17/2021 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca, iRhythm Technologies, Tyson Foods, and Clover Health Investments and Encourages Investors to Contact the Firm |
| 03/12/2021 |
GN
| ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important March 29 Deadline – AZN |
| 03/10/2021 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca, iRhythm Technologies, Tyson Foods, and Clover Health Investments and Encourages Investors to Contact the Firm |
| 03/03/2021 |
GN
| AZN BREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline – AZN |
| 03/03/2021 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 9F, AstraZeneca, iRhythm Technologies, and Tyson Foods and Encourages Investors to Contact the Firm |
| 03/01/2021 |
GN
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds AstraZeneca (AZN) Investors of Pending Securities Class Action, Encourages Investors Who Suffered Losses to Contact the Firm |
| 03/01/2021 |
GN
| SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against AstraZeneca PLC– AZN |
| 02/24/2021 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bit Digital, CleanSpark, 9F, Inc., and AstraZeneca and Encourages Investors to Contact the Firm |
| 02/19/2021 |
GN
| AZN DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AstraZeneca PLC– AZN |
| 02/17/2021 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca, iRhythm Technologies, Tyson Foods, and Clover Health Investments and Encourages Investors to Contact the Firm |
| 02/17/2021 |
GN
| BREAKING NEWS: ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline – AZN |
| 02/16/2021 |
GN
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds AstraZeneca (AZN) Investors of Securities Fraud Case Related to Potential COVID-19 Treatment Filed |
| 02/10/2021 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 9F, AstraZeneca, iRhythm Technologies, and Tyson Foods and Encourages Investors to Contact the Firm |
| 02/10/2021 |
GN
| BREAKING NEWS: ROSEN, NATIONAL TRIAL COUNSEL, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline – AZN |
| 02/04/2021 |
GN
| SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Reminds Investors of Pending Securities Class Action Lawsuit against AstraZeneca plc and Encourages Investors to Inquire About the Lead Plaintiff Position Before the March 29, 2021 Lead Plaintiff Deadline |
| 02/03/2021 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca and iRhythm Technologies and Encourages Investors to Contact the Firm |
| 02/02/2021 |
GN
| AZN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AstraZeneca PLC Shareholders of Class Action and Encourages Shareholders to Contact the Firm |
| 02/02/2021 |
GN
| Portnoy Law: Lawsuit Filed On Behalf of AstraZeneca, PLC Investors |
| 01/31/2021 |
GN
| BREAKING ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline – AZN |
| 01/28/2021 |
GN
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites AstraZeneca (AZN) Investors to Contact Firm, Securities Fraud Case Related to Potential COVID-19 Treatment Filed |
| 01/28/2021 |
GN
| Portnoy Law: Lawsuit Filed On Behalf of AstraZeneca PLC Investors |
| 01/11/2021 |
GN
| Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics |
| 12/15/2020 |
GN
| ALEXION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ALXN and Encourages Investors to Contact the Firm |
| 12/14/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Alexion Pharmaceuticals, Inc. Buyout |
| 12/02/2020 |
GN
| FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting |
| 11/25/2020 |
GN
| RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021 |
| 10/23/2020 |
GN
| First Patient Dosed in Monalizumab Phase 3 Clinical Trial Triggers $50M Payment From AstraZeneca |
| 10/14/2020 |
GN
| FibroGen to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2020 Reimagined |
| 10/08/2020 |
GN
| RedHill Biopharma Adds Israel Rights to Movantik® From AstraZeneca |
| 09/08/2020 |
GN
| Biopharma Leaders Unite to Stand with Science |
| 08/21/2020 |
GN
| RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease |
| 07/28/2020 |
GN
| Chi-Med's NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China |
| 05/29/2020 |
GN
| Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations |
|
|
|